MAXCLINIC CIRMAGE LIFTING (N&B LAB.Co.Ltd)


Welcome to the PulseAid listing for the MAXCLINIC CIRMAGE LIFTING drug offered from N&B LAB.Co.Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: N&B LAB.Co.Ltd
NON-PROPRIETARY NAME: ADENOSINE, GLYCYRRHIZA GLABRA
SUBSTANCE NAME: ADENOSINE; GLYCYRRHIZA GLABRA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: STICK
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-11-01
END MARKETING DATE: 0000-00-00


MAXCLINIC CIRMAGE LIFTING HUMAN OTC DRUG Details:

Item DescriptionMAXCLINIC CIRMAGE LIFTING from N&B LAB.Co.Ltd
LABELER NAME: N&B LAB.Co.Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: .009; .01(g/23g; g/23g)
START MARKETING DATE: 2016-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69058-100_e9f9069f-2ea8-466c-bef2-a08c7e73cc13
PRODUCT NDC: 69058-100
APPLICATION NUMBER:

Other ADENOSINE; GLYCYRRHIZA GLABRA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
N&B LAB.Co.LtdMAXCLINIC CIRMAGE LIFTING